### 77642 Federal Register / Vol. 75, No. 238 / Monday, December 13, 2010 / Notices

Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800.
John Dahlberg, Director, Division of Investigative Oversight, Office of Research Integrity.
[FR Doc. 2010–31168 Filed 12–10–10; 8:45 am]

**BILLING CODE 4150–31–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Agency for Healthcare Research and Quality** 

**Priority Setting for the Children’s Health Insurance Program**  **Reauthorization Act (CHIPRA) Pediatric Quality Measures Program—**  **Notice of Correction**

On pages 75469 and 75470, Volume 75, Number 232, Federal Register notice publication dated December 3, 2010, under **DATES** section, the correct date is: January 14, 2011. Also, on pages 75470 and 75471, under section

**SUPPLEMENTARY INFORMATION** all Web links that include the word: ‘‘ ahrg ’’ should be changed to: ‘‘AHRQ ’’

. Dated: December 7, 2010. Carolyn M. Clancy, Director, AHRQ.
[FR Doc. C1–2010–31110 Filed 12–10–10; 8:45 am]

**BILLING CODE 4160–90–M**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**[Docket Number NIOSH–219]**

**Implementation of Section 2695 (42 U.S.C. 300ff–131) of Public Law 111–**  **87: Infectious Diseases and Circumstances Relevant to Notification**  **Requirements**

**AGENCY :**  Centers for Disease Control and Prevention (CDC), Department of Health and Human Services.

**ACTION :**  General Notice and Request for Comments.

**SUMMARY :**  The Ryan White HIV/AIDS Treatment Extension Act of 2009 (Pub. L. 111–87) addresses notification procedures for designated officers, medical facilities, and State and community public health officers regarding exposure of emergency response employees (EREs) to potentially life-threatening infectious diseases. The Secretary of Health and Human Services (Secretary) has delegated authority to the Director of the Centers for Disease Control and Prevention (CDC) to issue a list of potentially life-threatening infectious diseases, including emerging infectious diseases, to which EREs may be exposed in responding to emergencies (including a specification of those infectious diseases that are routinely transmitted through airborne or aerosolized means); guidelines describing circumstances in which employees may be exposed to these diseases; and guidelines describing the manner in which medical facilities should make determinations about exposures. CDC is seeking comment on the list of diseases and guidelines contained in this notice.

**DATES :**  Comments must be received by February 11, 2011.

**ADDRESSES :**  Comments on the content of this Notice should be in writing and addressed to:

• E-mail: NIOSH Docket Officer, nioshdocket@cdc.gov. Include

‘‘ Infectious Diseases ’’ and ‘‘ 42 U.S.C. 300ff–131 ’’ in the subject line of the
message.

• Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS–C34, 4676 Columbia Parkway, Cincinnati, OH
45226.

• Internet: Federal e-rulemaking portal, http://www.regulations.gov. Follow the instructions for submitting
comments.

Instructions: All submissions received must include the agency name and docket number for this Notice. All comments will be posted without change to http://www.cdc.gov/niosh/ docket/archive/docket219.html, including any personal information provided. For detailed instructions on submitting comments and additional information about this process, see the

‘‘Public Participation’’ heading of the

**SUPPLEMENTARY INFORMATION** section of this document.

Docket: For access to the docket to read background documents or comments received, go to http:// www.cdc.gov/niosh/docket/archive/ docket219.html.

**FOR FURTHER INFORMATION CONTACT :**  Centers for Disease Control and Prevention, Attention: James Spahr, Associate Director, Emergency Preparedness & Response, Office of the Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop E20, Atlanta, GA 30333. Telephone (404) 498–6185 (this is not a toll-free number).

**SUPPLEMENTARY INFORMATION :**  Table of Contents
Public Participation Introduction Definitions Part I. List of potentially life-threatening infectious diseases to which emergency response employees may be exposed. Part II. Guidelines describing the circumstances in which such employees may be exposed to such diseases. Part III. Guidelines describing the manner in which medical facilities should make determinations for purposes of section 2695B(d) [42 U.S.C. 300ff–133(d)]. Addendum: References

Public Participation

Interested persons or organizations are invited to participate in this request for public comments by submitting written views, arguments, recommendations, and data. Comments are invited on any topic related to this proposal. In particular, CDC invites comment on the list of infectious diseases and both sets of guidelines discussed herein.

Comments submitted by e-mail or mail should be titled ‘‘Docket #219 Public Comments, ’’ addressed to the

‘‘NIOSH Docket Officer, ’’ and identify the author(s), return address, and a phone number, in case clarification is needed. Comments can be submitted by e-mail to nioshdocket@cdc.gov as e-mail text or as a Microsoft Word file attachment. Printed comments can be sent to the NIOSH Docket Office at the address above. All communications received on or before the closing date for comments will be fully considered by CDC in developing a final list of infectious diseases and guidelines which will be published in the Federal Register.

Introduction

The Ryan White HIV/AIDS Treatment Extension Act of 2009 (Pub. L. 111–87) amended the Public Health Service Act (PHS Act, 42 U.S.C. 201–300ii), including the addition of a Part G to Title XXVI, which addresses notification procedures and requirements for medical facilities, State public health officers and their designated officers regarding exposure of EREs to potentially life-threatening infectious diseases. ( See Title XXVI, Part G of the PHS Act, codified as amended at 42 U.S.C. 300ff–131 to 300ff–140.)

For purposes of these notification requirements, Section 2695 [42 U.S.C. 300ff–131] requires the Secretary of Health and Human Services (Secretary) to develop and disseminate:

(1) A list of potentially lifethreatening infectious diseases,